Published in Biomaterials on February 01, 2002
Methyl methacrylate and respiratory sensitization: a critical review. Crit Rev Toxicol (2011) 0.75
Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy. Front Physiol (2012) 1.45
Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma. Cancer Res (2009) 1.37
Identification of RB1CC1, a novel human gene that can induce RB1 in various human cells. Oncogene (2002) 1.35
Growth factors in bone repair. Chir Organi Mov (2008) 1.23
MicroRNA expression profiling of human bone marrow mesenchymal stem cells during osteogenic differentiation reveals Osterix regulation by miR-31. Gene (2013) 1.20
MET overexpression turns human primary osteoblasts into osteosarcomas. Cancer Res (2006) 1.09
Effectiveness of insulin-like growth factor I receptor antisense strategy against Ewing's sarcoma cells. Cancer Gene Ther (2002) 1.09
The effect of perineurotomy on nerve regeneration in diabetic rats: how to export it to the clinical setting? Plast Reconstr Surg (2013) 1.08
Sensitivity to implant materials in patients with total knee arthroplasties. Biomaterials (2007) 1.06
Sensitivity to implant materials in patients undergoing total hip replacement. J Biomed Mater Res B Appl Biomater (2006) 1.04
Xanthoma of bone: first sign of hyperlipidemia type IIB: a case report. Clin Orthop Relat Res (2003) 1.02
Treatment of gingival recession defects with a coronally advanced flap and a xenogeneic collagen matrix: a multicenter randomized clinical trial. J Clin Periodontol (2012) 1.02
Immunological changes in patients with primary osteoarthritis of the hip after total joint replacement. J Bone Joint Surg Br (2003) 1.00
Polylactic acid fibre-reinforced polycaprolactone scaffolds for bone tissue engineering. Biomaterials (2008) 1.00
Apatite formation on bioactive calcium-silicate cements for dentistry affects surface topography and human marrow stromal cells proliferation. Dent Mater (2010) 0.98
Does ion release differ between hip resurfacing and metal-on-metal THA? Clin Orthop Relat Res (2008) 0.97
Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients' bed. J Transl Med (2013) 0.97
V-ATPase is a candidate therapeutic target for Ewing sarcoma. Biochim Biophys Acta (2013) 0.97
The role of hydroxyapatite as solid signal on performance of PCL porous scaffolds for bone tissue regeneration. J Biomed Mater Res B Appl Biomater (2008) 0.96
The combined use of mesenchymal stromal cells and scaffolds for bone repair. Curr Pharm Des (2012) 0.96
Height as a risk factor for osteosarcoma. J Pediatr Hematol Oncol (2005) 0.95
Development of the foremost light-curable calcium-silicate MTA cement as root-end in oral surgery. Chemical-physical properties, bioactivity and biological behavior. Dent Mater (2011) 0.95
Increased osteoclast activity is associated with aggressiveness of osteosarcoma. Int J Oncol (2008) 0.94
Pre-operative diagnosis of infection in total knee arthroplasty: an algorithm. Knee Surg Sports Traumatol Arthrosc (2009) 0.94
Sphere-forming cell subsets with cancer stem cell properties in human musculoskeletal sarcomas. Int J Oncol (2013) 0.93
Osteogenic properties of late adherent subpopulations of human bone marrow stromal cells. Histochem Cell Biol (2009) 0.92
Preparation method and growth factor content of platelet concentrate influence the osteogenic differentiation of bone marrow stromal cells. Cytotherapy (2013) 0.92
Osteoblasts from a mandibuloacral dysplasia patient induce human blood precursors to differentiate into active osteoclasts. Biochim Biophys Acta (2011) 0.91
In vitro blockade of receptor activator of nuclear factor-kappaB ligand prevents osteoclastogenesis induced by neuroblastoma cells. Int J Cancer (2004) 0.91
Knee joint arthroplasty after tibial osteotomy. Int Orthop (2009) 0.90
Gene expression patterns related to osteogenic differentiation of bone marrow-derived mesenchymal stem cells during ex vivo expansion. Tissue Eng Part C Methods (2010) 0.90
Platelet-rich plasma impairs osteoclast generation from human precursors of peripheral blood. J Orthop Res (2010) 0.89
Potential role of tartrate-resistant acid phosphatase 5b (TRACP 5b) as a surrogate marker of late loosening in patients with total hip arthroplasty: a cohort study. J Orthop Res (2010) 0.89
New Portland cement-based materials for endodontics mixed with articaine solution: a study of cellular response. J Endod (2008) 0.89
Association of two gene polymorphisms with osteoarthritis secondary to hip dysplasia. Clin Orthop Relat Res (2002) 0.88
Expression profiling of osteosarcoma cells transfected with MDR1 and NEO genes: regulation of cell adhesion, apoptosis, and tumor suppression-related genes. Lab Invest (2003) 0.88
Biomimetic calcium-silicate cements aged in simulated body solutions. Osteoblast response and analyses of apatite coating. J Appl Biomater Biomech (2010) 0.88
Idiopathic and secondary osteonecrosis of the femoral head show different thrombophilic changes and normal or higher levels of platelet growth factors. Acta Orthop (2011) 0.88
Inhibition of angiogenesis via FGF-2 blockage in primitive and bone metastatic renal cell carcinoma. Anticancer Res (2007) 0.87
Is wear debris responsible for failure in alumina-on-alumina implants? Acta Orthop (2009) 0.87
Paracrine inhibition of osteoblast differentiation induced by neuroblastoma cells. Int J Cancer (2008) 0.87
V-ATPase as an effective therapeutic target for sarcomas. Exp Cell Res (2014) 0.87
Isolation, characterisation and osteogenic potential of human bone marrow stromal cells derived from the medullary cavity of the femur. Chir Organi Mov (2008) 0.87
Profile of toll-like receptor-positive cells in septic and aseptic loosening of total hip arthroplasty implants. J Biomed Mater Res A (2010) 0.86
Insulin receptor isoforms are differently expressed during human osteoblastogenesis. Differentiation (2012) 0.86
Biocompatibility of poly(D,L-lactide-co-glycolide) nanoparticles conjugated with alendronate. Biomaterials (2008) 0.85
Serum levels of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand as markers of periprosthetic osteolysis. J Bone Joint Surg Am (2006) 0.85
Molecular basis of osteoclastogenesis induced by osteoblasts exposed to wear particles. Biomaterials (2005) 0.85
Histogenetic characterization of giant cell tumor of bone. Clin Orthop Relat Res (2008) 0.85
IGF2 derived from SH-SY5Y neuroblastoma cells induces the osteoclastogenesis of human monocytic precursors. Exp Cell Res (2011) 0.84
Sustained autocrine induction and impaired negative feedback of osteoclastogenesis in CD14(+) cells of giant cell tumor of bone. Am J Pathol (2013) 0.84
A novel biomaterial for osteotropic drug nanocarriers: synthesis and biocompatibility evaluation of a PLGA-ALE conjugate. Nanomedicine (Lond) (2009) 0.84
Enhancing osteoconduction of PLLA-based nanocomposite scaffolds for bone regeneration using different biomimetic signals to MSCs. Int J Mol Sci (2012) 0.84
Serum ion levels after ceramic-on-ceramic and metal-on-metal total hip arthroplasty: 8-year minimum follow-up. J Orthop Res (2008) 0.84
Plasma levels of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in patients with neuroblastoma. Int J Cancer (2006) 0.83
Inhibition of angiogenic activity of renal carcinoma by an antisense oligonucleotide targeting fibroblast growth factor-2. Anticancer Res (2005) 0.83
Biological basis for the use of autologous bone marrow stromal cells in the treatment of congenital pseudarthrosis of the tibia. Bone (2009) 0.82
Endothelial cells incubated with platelet-rich plasma express PDGF-B and ICAM-1 and induce bone marrow stromal cell migration. J Orthop Res (2009) 0.82
Neuroblastoma and bone metastases: clinical significance and prognostic value of Dickkopf 1 plasma levels. Bone (2010) 0.82